Document is current
Any future updates will be listed below
-
Authors
Gehder, Sara
Brückner, Stefanie
Gilbert, Stephen
Goeldner, Moritz
-
Funding
Funding for this research was provided by:
NextGenerationEU program - Project PATH (16KISA100K)
NextGenerationEU program - Project PATH (16KISA100K)
- License Information
-
More Information
Article History
Received: 29 August 2025
Accepted: 9 March 2026
First Online: 8 April 2026
Competing interests
: S.B. declares no competing interests. S.Ge. is employed by a statutory health insurance company in Germany, with no relation to this work. M.G. has previously consulted DiGA manufacturers, unrelated to this study. S.Gi. is an Advisory Group member for the EY-coordinated “Study on Regulatory Governance and Innovation in Medical Devices” for the European Commission (DG SANTE). He has or has had consulting relationships with Una Health GmbH, Lindus Health Ltd., Flo Health UK Limited, Thymia Ltd., FORUM Institut für Management GmbH, High-Tech Gründerfonds Management GmbH, haleon plc and Ada Health GmbH and holds share options in Ada Health GmbH. S.Gi. is a News and Views Editor for npj Digital Medicine. S.Gi. played no role in the editorial handling of this article.
